Kuwait

Jordanian drugmaker Hikma has announced that it is to acquire German oncology firm Ribosepharm in a deal worth US$45mn. This marks Hikma's second purchase in the last nine months... 2007-01-24

According to recently released data, the Jordanian drug industry exported products worth JOD198.6mn (US$280mn) in 2005, which is directly in line with BMI estimates. However, BMI... 2007-01-10

The Middle East is becoming an attractive destination for counterfeiters, according to delegates at the Regional Anti-Counterfeiting Forum, which was recently held in Amman, Jordan.... 2006-12-13

Jordanian drugmaker Dar Al Dawa (DAD) has announced a 19.2% growth in sales for the first three quarters of the year to JOD28.36 (US$40.02mn). On the back of this strong performance... 2006-11-13

Jordanian drugmaker Hikma has announced that it expects lower generics sales for 2006, due to the weaker than expected performance of its new products. Like most generic firms, Hikma... 2006-10-25

Jordan's Health Minister has denied claims that the government is planning to fully privatise the health sector, citing the fact that three public hospitals have recently been constructed.... 2006-10-23

Egypt has promised to remove all obstacles restricting imports of Jordanian pharmaceuticals, bringing to an end a long running dispute between the countries. The pledge came after... 2006-10-02

Jordan-based generic drugmaker Hikma Pharmaceuticals has unveilled a 9.5% increase in profits for H106, driven by strong revenue growth for is branded and injectable drug businesses.... 2006-09-13

Jordanian drugmaker Hikma is aiming to double or even triple its sales in Middle East and North Africa (MENA) in the coming years by acquiring companies and expanding existing businesses.... 2006-07-12

The Kuwaiti pharmaceutical market can be expected to continue to grow steadily, if moderately, in the short term. Offsetting this expected growth is the government's cost-containment... 2006-05-16